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We develop integrated instruments and platforms suitable for economical, frequent space access 
for autonomous life science experiments and processes in outer space.  The technologies 
represented by three of our recent “free-flyer small-satellite” missions are the basis of a rapidly 
growing toolbox of miniaturized biologically/biochemically-oriented instrumentation now 
enabling a new generation of in-situ space experiments. 
 
Autonomous small satellites (~ 1 – 50 kg) are less expensive to develop and build than “full-
size” spacecraft and not subject to the comparatively high costs and scheduling challenges of 
human-tended experimentation on the International Space Station, Space Shuttle, and 
comparable platforms.  A growing number of commercial, government, military, and civilian 
space launches now carry small “secondary” science payloads at far lower cost than dedicated 
missions; the number of opportunities is particularly large for so-called cube-sat and multicube 
satellites in the 1 – 10 kg range.  The recent explosion in nano-,  micro-, and miniature 
technologies, spanning fields from telecommunications to materials to bio/chemical analysis, 
enables development of remarkably capable autonomous miniaturized instruments to accomplish 
remote biological experimentation.  High-throughput drug discovery, point-of-care medical 
diagnostics, and genetic analysis are applications driving rapid progress in autonomous 
bioanalytical technology.  
 
Three of our recent missions exemplify the development of miniaturized analytical payload 
instrumentation: GeneSat-1 (launched: December 2006), PharmaSat (launched: May 2009), and 
O/OREOS (organism/organics exposure to orbital stresses; scheduled launch: May 2010).  We 
will highlight the overall architecture and integration of fluidic, optical, sensor, thermal, and 
electronic technologies and subsystems to support and monitor the growth of microorganisms in 
culture in these small autonomous space satellites, including real-time tracking of their culture 
density, gene expression, and metabolic activity while in the space environment.  Flight data and 
results will be presented from GeneSat-1, which tracked gene expression levels of GFP-labeled 
E. coli and from PharmaSat, which monitored the dose dependency of an antifungal agent 
against S. cerevisiae.  The O/OREOS SESLO instrument, which will study the effects of 
radiation and microgravity upon the viability and growth characteristics of B. subtilis and the 
halophile Halorubrum chaoviatoris for periods of 0 - 6 months in space, will be described as 
well.  The ongoing expansion of the small satellite toolbox of biological technologies will be 
summarized.    
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